Invention could help reduce highway repairs

(PhysOrg.com) -- Ohio University has licensed a new device that tests the durability of highway asphalt to an Athens, Ohio-based company founded by the engineering professor who invented the technology.

Sang-Soo Kim, an associate professor of civil engineering in the Russ College of Engineering and Technology, developed the Asphalt Binder Cracking Device (ABCD) in a quest to find a reliable way to determine which types of pavement hold up to the stress of highway traffic and cold weather extremes. State transportation departments spend billions of dollars annually to repair cracks, ruts and potholes on the nation’s roadways.

With help from Ohio University’s Technology Transfer Office and Innovation Center, Kim founded EZ Asphalt to commercialize his invention. Ohio University owns the patent on the device, and Kim has licensed the technology back from the institution in order to market it to government agencies, private corporations and university research laboratories.

“The Asphalt Binder Cracking Device is an excellent example of how Ohio University researchers are developing new technologies that solve real-world problems,” said Lisa Rooney, director of the Technology Transfer Office. “We’re excited about taking this invention to the marketplace.”

The ABCD is about the size and shape of a round beverage coaster and contains a metal testing ring. Kim pours different types of asphalt into the device, and places it a cooling chamber that resembles a small stainless steel refrigerator. An off-the-shelf computer program records the coldest temperature at which the asphalt will crack. The chamber can check 16 specimens at once, and the testing process takes three hours.

“There’s no comparable technology out there, and people like the ABCD because it’s an easy, simple process,” said Kim, who is a member of Ohio University’s Ohio Research Institute for Transportation and the Environment.

Kim projects that he could sell 1,000 units of the ABCD in five years.

In preliminary tests on pavement samples from Pennsylvania and Canada, the ABCD provided more accurate, consistent results than conventional estimates of asphalt cracking, he said.

Just one cold snap can create a crack that deteriorates an entire roadway, the engineer explained. Once water seeps into the pavement, the structure weakens. Kim estimates that the United States spends tens of billions of dollars each year to seal cracks and repair road damage.

That’s motivated Kim and student researchers in the Russ College of Engineering and Technology to spend several years developing the right design for the ABCD. The work has provided a great experience for engineering students, Kim said, as they’ve learned how the problem-solving skills honed in the laboratory and classroom can help them make positive contributions to society.

“Engineers are very practical – they want to solve real-world problems,” he said. “It’s really satisfying when you can do that.”

Kim received a patent on the device in August 2007. In January, the Federal Highway Administration provided $239,000 in funding to help him commercialize the technology. Purdue University and the University of Wisconsin-Madison will conduct additional testing with the ABCD to determine if improvements are needed, Kim said.

The ABCD is one of several technologies that Ohio University has licensed to companies for commercialization. In fiscal year 2008, the university received $5.9 million in royalty income, much of which stems from a license for a 1988 research discovery at the Edison Biotechnology Institute. The work led to the development of a drug for people with acromegaly, a form of gigantism that creates excessive growth of bones and organs in adults.

Provided by Ohio University

Related stories:

Iressa proves just as effective as chemotherapy for lung cancer
Gefitinib, also known as Iressa, the once-promising targeted therapy for the treatment of non-small cell lung cancer, has proven as effective as chemotherapy as a second-line therapy for the disease with far fewer side effects, according to an international Phase III clinical trial, led by researchers at The University of Texas M. D. Anderson Cancer Center.
Stress hinders rats' decision-making abilities
(PhysOrg.com) -- A little bit of stress goes a long way and can have far-reaching effects. Neuroscientists from the University of Washington have found that a single exposure to uncontrollable stress impairs decision making in rats for several days, making them unable to reliably seek out the larger of two rewards.
New Virtual Tool Can Train Athlete Brains to React 53 Percent Faster, Improve Their Game
All great athletes know that in order to perform well, they can't just depend on their physical capabilities. Speed and efficiency in decision-making are just as essential. Two researchers from the School of Optometry of the Université de Montréal have discovered how to train the brain of athletes to improve their overall athletic performance.
Women's Gains in Politics Not Seen in Board Rooms, CEO Offices
(PhysOrg.com) -- Half of California's 400 largest public companies have no women in top executive offices, according to a study reported today by University of California, Davis, researchers. Almost half do not have a woman on the board of directors. Nearly a third -- including household names McAfee, Quicksilver and Hansen Natural -- do not have a woman in either a top executive post or on the governing board.
No honeymoon replays: People don't want to taint special memories
That unforgettable honeymoon has a special place in your memory -- so special
that you might be reluctant to try to repeat it. A new study in the Journal of
Consumer Research says people tend to treat their memories of previous special
experiences as assets to be protected.
Nanotube Construction Set
(PhysOrg.com) -- Organic nanotubes could make rapid strides as functional nanomaterials in a new approach to nanoelectronics and biomedicine, as they can be made of easily varied and modified building blocks.
Findings suggest nanowires ideal for electronics manufacturing
(PhysOrg.com) -- Researchers have discovered that tiny structures called silicon nanowires might be ideal for manufacturing in future computers and consumer electronics because they form the same way every time.
Novel 4-drug combination proves safe for lung cancer treatment
The four drug-combination of carboplatin and paclitaxel, with the targeted therapies bevacizumab (Avastin) and cetuximab (Erbitux), is safe and may improve survival for patients with advanced lung cancer, according to a cooperative group study led by The University of Texas M. D. Anderson Cancer Center.

News discussion:

Technology news